iTeos Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 3.65 M | $21.78 M | 74.41% | 8.44% |
BVF INC/IL | 05/15/2025 | 3.08 M | $18.36 M | 32.26% | 7.11% |
MPM ASSET MANAGEMENT LLC | 05/15/2025 | 2.74 M | $16.35 B | 0.00% | 6.33% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.69 M | $16.05 M | 1,112.90% | 6.22% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.75 M | $10.45 M | 90.61% | 4.05% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 536.79 K | $3.20 M | 14.17% | 1.24% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 518.40 K | $3.09 M | -31.83% | 1.20% |
05/12/2025 | 303.65 K | $1.81 M | 100.00% | 0.70% | |
ALMITAS CAPITAL LLC | 05/15/2025 | 275.12 K | $1.64 B | 0.00% | 0.64% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 213.35 K | $1.27 M | 13.27% | 0.49% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 154.49 K | $922.32 K | -69.70% | 0.36% |
K2 PRINCIPAL FUND, L.P. | 05/15/2025 | 120.50 K | $719.39 K | -34.69% | 0.28% |
MARSHALL WACE, LLP | 05/15/2025 | 119.56 K | $713.76 K | 100.00% | 0.28% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 107.76 K | $643.35 K | -44.72% | 0.25% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 57.88 K | $345.53 K | -8.10% | 0.13% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 44.15 K | $263.56 K | -55.27% | 0.10% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 40.68 K | $242.83 K | 265.59% | 0.09% |
05/06/2025 | 38.90 K | $232.23 K | 0.00% | 0.09% | |
ENGINEERS GATE MANAGER LP | 05/15/2025 | 36.81 K | $219.76 K | 100.00% | 0.09% |
K2 PRINCIPAL FUND, L.P. | 05/15/2025 | 29.18 K | $174.19 K | 100.00% | 0.07% |
ALPS ADVISORS INC | 04/30/2025 | 28.65 K | $171.02 K | -3.03% | 0.07% |
MAN GROUP PLC | 05/15/2025 | 22.53 K | $134.52 K | -22.75% | 0.05% |
VIRTUS INVESTMENT ADVISERS, INC. | 05/15/2025 | 20.66 K | $123.36 K | 100.00% | 0.05% |
OXFORD ASSET MANAGEMENT LLP | 05/15/2025 | 19.89 K | $118.74 K | 100.00% | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 18.28 K | $109.13 K | 0.00% | 0.04% |
Y-INTERCEPT (HONG KONG) LTD | 05/06/2025 | 18.12 K | $108.20 K | -1.86% | 0.04% |
TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 17.65 K | $105.38 K | 100.00% | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 16.34 K | $97.57 K | 54.07% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 15.98 K | $95.40 K | 4.59% | 0.04% |
CLEAR HARBOR ASSET MANAGEMENT, LLC | 05/15/2025 | 12.50 K | $74.63 K | 0.00% | 0.03% |
PALOMA PARTNERS MANAGEMENT CO | 05/15/2025 | 10.95 K | $65.35 K | 100.00% | 0.03% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/30/2025 | 7.33 K | $43.75 K | -5.41% | 0.02% |
05/09/2025 | 5.21 K | $31.12 K | 0.00% | 0.01% | |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 04/24/2025 | 1.22 K | $7.72 K | 0.41% | 0.00% |
VERSANT CAPITAL MANAGEMENT, INC | 04/03/2025 | 985 | $5.88 K | 100.00% | 0.00% |
HANTZ FINANCIAL SERVICES, INC. | 05/12/2025 | 100 | $1.00 K | 0.00% | 0.00% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 1 | $6 | -99.98% | 0.00% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
UBS OCONNOR LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 05/07/2025 | 0 | $0 | -100.00% | 0.00% |
MARQUETTE ASSET MANAGEMENT, LLC | 04/09/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
FOX RUN MANAGEMENT, L.L.C. | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
LMR PARTNERS LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
VIRTUS ETF ADVISERS LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
EMPOWERED FUNDS, LLC | 05/16/2025 | 0 | $0 | -100.00% | 0.00% |
iTeos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:
Point72 (DIFC) Ltd: 0
Zurcher Kantonalbank (Zurich Cantonalbank): 0
XTX Topco Ltd: 0
BALYASNY ASSET MANAGEMENT L.P.: 0
Virtus ETF Advisers LLC: 0
Virtu Financial LLC: 0
85.48% of iTeos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.41 M shares in the last 24 months. This purchase volume represents approximately $102.00 M in transactions.